New Chikungunya vaccine for adolescents from 12 and adults

View source ↗

Summary

EMA approved Vimkunya, a chikungunya vaccine, for adolescents aged 12 years and older and adults; the review was expedited due to public health interest.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya

Drugs mentioned

• Vimkunya

Snippet

The review of Vimkunya was expedited because of public health interest